Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Nephrology
 Disease Category: Bladder Disorders
Location: United States, VA

Trial Information

Overactive Bladder study- (DR-OXY-301)

The purpose of this research is to study the safety and effectiveness of an experimental vaginal ring that administers a medication called oxybutynin in subjects with an overactive bladder who have symptoms of pure or predominantly urge incontinence, urgency and frequency. We will be evaluating the safety and effectiveness of two doses of DR-3001 vs placebo taken for 12 weeks. Patients will be randomly assigned to one of 3 vaginal rings, 4mg ring, 6 mg ring, or placebo ring. We are looking for woman 18 and older with a history and presentation consistent with pure or predominantly urge incontinence for 6months or longer.

Duration of study: 5 months with 6 visits.
Compensation: up to $600

CONRAD Clinical Research Center
601 Colley Avenue
Norfolk, VA 23507
Phone: 757-446-5808
Fax: 757-446-8469

View Map

Research Center Information: CONRAD Clinical Research Center

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.